{"url_path":"/sec/maci/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/2016221/0001213900-26-056836-index.html","accession_number":"0001213900-26-056836","cik":"0002016221","ticker":"MACI","issuer_name":"Melar Acquisition Corp. I/Cayman","edgar_url":"https://www.sec.gov/Archives/edgar/data/2016221/0001213900-26-056836-index.html","primary_entity_key":"0002016221","primary_entity_name":"Melar Acquisition Corp. I/Cayman"},"word_count":525,"has_tables":true,"body_markdown":"**Item 1A. Risk Factors**\n\n \n\nAs a smaller reporting company under Rule\n12b-2 of the Exchange Act, we are not required to include risk factors in this Report. For additional risks relating to our\noperations, the section titled “Risk Factors” contained in our IPO Registration Statement and 2025 Annual Report. Any of\nthese factors could result in a significant or material adverse effect on our results of operations or financial condition.\nAdditional risks could arise that may also affect our business or ability to consummate an initial Business Combination. We may\ndisclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.\n\n \n\n**We may seek to extend the Combination Period,\nwhich could reduce the amount held in our Trust Account and have adverse effects on our Company.**\n\n \n\nIf we are unable to consummate our initial Business Combination on or before June 20, 2026, we may seek shareholder approval to\nextend the Combination Period by amending our Amended and Restated Articles. In such event, our Public Shareholders will be provided the\nopportunity to have all or a portion of their Public Shares redeemed. Any redemptions will reduce the amount held in our Trust Account,\nthe effect of which may adversely affect our ability to consummate our initial Business Combination and may also impair our ability to\nmaintain our Nasdaq listing.\n\n \n\n**Certain agreements related to the Initial\nPublic Offering may be amended, or their provisions waived, without shareholder approval.**\n\n \n\nCertain of the agreements related to the Initial Public Offering to which we are a party may be amended, or their\nprovisions waived, without shareholder approval. Such agreements include the (i) Underwriting Agreement, (ii) the Letter Agreement, (iii)\nthe Registration Rights Agreement, (iii) the Private Placement Warrants Purchase Agreements and (iv) the Administrative Services Agreement.\nThese agreements contain various provisions that our Public Shareholders might deem to be material. For example, our Letter Agreement\nand the Underwriting Agreement contain certain lock-up provisions with respect to the Founder Shares and other securities held by our\nSponsor, officers and directors, subject to certain exceptions. Amendments or waivers to such agreements would require the consent of\nthe applicable parties thereto and, in certain cases, the consent of the underwriters of the Initial Public Offering. Any such modification,\nsuch as an amendment to shorten lock-up restrictions, may benefit our Sponsor, officers and/or directors. Any such amendments would not\nrequire approval from our shareholders, may result in the completion of our initial Business Combination that may not otherwise have been\npossible, and may have an adverse effect on the value of an investment in our securities. For example, although we would not amend lock-up\nprovisions to permit securities held by our Sponsor to be freely sold prior to our initial Business Combination, we may amend such provisions\nto permit them to be freely sold after the Business Combination earlier than they would otherwise be permitted, which may have an adverse\neffect on the price of our securities.\n\n \n\nFor the risks related to Everli and the Everli\nBusiness Combination, please see the registration statement on Form S-4 for the Everli Business Combination, once filed."}